Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cephea Valve Technologies Inc.

cephea.com

Latest From Cephea Valve Technologies Inc.

Edwards Declares Victory In Transcatheter Mitral Valve Contract Suit

A jury recommended a $70m award to Edwards Lifesciences unit CardiAQ based on findings that another firm, Neovasc, breached a supplier contract and used CardiAQ's trade secrets to develop a competing transcatheter mitral valve device.

Medical Device Legal Issues

Millipede's Play In Percutaneous Mitral Valve Repair

As medtech strategics race to develop a percutaneously deliverable replacement mitral valve for patients with mitral regurgitation, start-ups tackle an array of mitral repair strategies. Building on a tried-and-true surgical approach, Millipede is developing a catheter-delivered adjustable annuloplasty ring that reduces annular dilation of the mitral valve in order to reduce or eliminate mitral regurgitation.

Medical Device

Transcatheter Mitral Valve Therapy: Opportunities And Challenges

Amid the clinical and commercial success of transcatheter aortic valve replacement (TAVR), companies are preparing for what is predicted to be an even larger market in minimally invasive mitral valve replacement and repair technologies; in the summer of 2015, strategics made huge bets in quick succession on promising replacement valves. There is a great deal of activity on the repair side, too, and debate is ongoing about technical and regulatory challenges and which technologies are likely to be appropriate for patients with various types of mitral valve regurgitation.

Medical Device Innovation

Start-Up Quarterly Statistics, Q3 2015

Start-ups raised $2.57 billion in Q3. Biopharma companies penned 23 alliances; 11 acquisitions were signed, none in the diagnostics industry.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cephea Valve Technologies Inc.
  • Senior Management
  • Thierry Thaure, CEO
    Daniel Wallace, VP, Prod. Dev.
  • Contact Info
  • Cephea Valve Technologies Inc.
    Phone: (425) 208-5503
    3050 Three Springs Ct.
    San Jose, CA 95140
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register